BOSTON--(BUSINESS WIRE)--
NeuroMetrix, Inc. (NASDAQ:NURO) today announced that its Quell Wearable
Pain Relief Technology will be featured at the PAINWeek 2015 National
Conference this week in Las Vegas, Nevada. PAINWeek is the nation's
largest pain conference for frontline clinicians with an interest in
pain management. Over 2100 physicians and other health care
professionals are expected to attend.
"Quell is an ideal option for pain medicine physicians managing
challenging chronic pain conditions such as painful diabetic neuropathy,
sciatica and fibromyalgia," said Shai N. Gozani, M.D., Ph.D. President
and CEO of NeuroMetrix, Inc. "The PAINWeek meeting is a great venue to
share Quell technology and our latest clinical data with the pain
management community."
A study abstract, "Treatment of Chronic Pain with a Novel Wearable
Transcutaneous Electrical Nerve Stimulator," was accepted for poster
presentation at the conference scientific sessions. Dr. Gozani will
present the study results at the Poster Reception on September 10.
About Quell Wearable Pain Relief Device
Quell is an easy-to-use, over-the-counter device for relief of chronic
pain. This wearable device utilizes NeuroMetrix's wearable intensive
nerve stimulation (WINS) technology to provide pain relief. Quell is
currently available through select healthcare professionals and online
at www.QuellRelief.com.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150908006495/en/
Investor Relations:
NeuroMetrix, Inc.
Thomas T. Higgins,
781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
